Company

Empress Therapeutics

Biotechnology Research 99 Coolidge Ave 25 employees

Employees: 25
Contacts: 3
Emails: 3
Phones: 1

www.empresstx.com LinkedIn Crunchbase

Empress Therapeutics Overview

Headquarters: 99 Coolidge Ave
Website: www.empresstx.com
Industry: Biotechnology Research
Employees: 25
Founded: 2022
Funding: 50.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in small molecule drug discovery has been instrumental to our mission: using genetics and AI to uncover drug-like molecules encoded in the human body.

About Empress Therapeutics

Founded by Flagship Pioneering in 2020, Empress Therapeutics generates good medicines, fast, by starting with chemistry inside the human body. The Empress Chemilogics(TM) platform uses novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body to create first- or best-in-class oral medicines for a broad range of diseases quickly, predictably, and cost-effectively.

Empress Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Empress Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Arjeta T.	Open to Possibilities	Queens, New York, United States	View
Jason Park	Scientist, Founder, CEO at Empress Tx	Cambridge, Massachusetts, United States	Email Phone
Murray Mckinnon, Ph.d.	Chief Scientific Officer, Empress	Washington Crossing, Pennsylvania, United States	Email
Virginia Finnerty-Brooks		San Francisco, California, United States	Email